1 |
Murias, M., Jager, W., Handler, N., Erker, T., Horvath, Z., Szekeres, T., Nohl, H. and Gille, L. (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship., Biochem. Pharmacol. 69, 903-912.
DOI
ScienceOn
|
2 |
Heiss, E. H., Schilder, Y. D. and Dirsch, V. M. (2007) Chronic treatment with resveratrol induces redox stressand ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J. Biol. Chem. 282, 26759-26766.
DOI
ScienceOn
|
3 |
Sunila, E. S. and Kuttan, G. (2004) Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J. Ethnopharmacol. 90, 339-346.
DOI
ScienceOn
|
4 |
Mikkelsen, R. B. and Wardman, P. (2003) Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22, 5734-5754.
DOI
ScienceOn
|
5 |
Ahmed, K. M. and Li, J. J. (2008) NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic. Biol. Med. 44, 1-13.
DOI
ScienceOn
|
6 |
Creagh, E. M. and Martin, S. J. (2001) Caspases: cellular demolition experts. Biochem. Soc. Trans. 29, 696-702.
DOI
ScienceOn
|
7 |
Li, H., Zhu, H., Xu, C. J. and Yuan, J. (1998) Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
DOI
ScienceOn
|
8 |
Pastorino, J. G., Simbula, G., Yamamoto, K., Glascott, P. A., Rothman, R. J. and Farber, J. L. (1996) The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271, 29792-29798.
DOI
ScienceOn
|
9 |
Tauskela, J. S., Hewitt, K., Kang, L. P., Comas, T., Gendron, T., Hakim, A., Hogan, M., Durkin, J. and Morley, P. (2001) Evaluation of glutathione-sensitive fluorescent dyes in conical culture. Glia 30, 329-341.
|
10 |
Tak, J. K. and Park, J.-W. (2009) The use of ebselen for radioprotection in cultured cells and mice. Free Radic. Biol. Med. 46, 1177-1185.
DOI
ScienceOn
|
11 |
Kabakov, A. E., Kudryavtsev, V. A. and Gabai, V. L. (2010) Hsp90 inhibitors as promising agents for radiotherapy. J. Mol. Med. 88, 241-247.
DOI
ScienceOn
|
12 |
Camphausen, K. and Tofilon, P. J. (2004) Combining radiation and molecular targeting in cancer therapy. Cancer Biol. Ther. 3, 247-250.
DOI
|
13 |
Moeller, B. J., Dreher, M. R., Rabbani, Z. N., Schroeder, T., Cao, Y., Li, C. Y. and Dewhirst, M. W. (2005) Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cells 8, 99-110.
DOI
ScienceOn
|
14 |
Smets, L. A. (1994) Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs 5, 3-9.
|
15 |
von Sonntag, C. (2006) Free Radical-induced DNA Damage and Its Repair. A Chemical Perspective. Springer, Berlin.
|
16 |
Pinthus, J. H., Bryskin, I., Trachtenberg, J., Lu, J. P., Singh, G., Fridman, E. and Wilson, B. C. (2007) Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia 9, 68-80.
DOI
|
17 |
Wang, J. and Yi, J. (2008) Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol. Ther. 7, 1875-1884.
DOI
ScienceOn
|
18 |
Ben-Yoseph, O. and Ross, B. D. (1994) Oxidation therapy: the use of a reactive oxygen species-generating enzyme system for tumor treatment. Br. J. Cancer 70, 1131-1135.
DOI
ScienceOn
|
19 |
Yoshikawa, T., Kokura, S., Tainaka, K., Naito, Y. and Kondo, M. (1995) A novel cancer therapy based on oxygen radicals. Cancer Res. 55, 1617-1620.
|
20 |
Baur, J. A. and Sinclair, D. A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506.
DOI
ScienceOn
|
21 |
Sundaresan, M., Yu, Z. X., Ferrans, C. J., Irani, K. and Finkel, T. (1995) Requirement for generation of for platelet-derived growth factor signal transduction. Science 270, 296-299.
DOI
ScienceOn
|
22 |
Orallo, F. (2006) Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr. Med. Chem. 13, 87-98.
DOI
ScienceOn
|